Insider Selling: Thermo Fisher Scientific Inc. (TMO) Insider Sells 6,000 Shares of Stock

Thermo Fisher Scientific Inc. (NYSE:TMO) insider Patrick M. Durbin sold 6,000 shares of Thermo Fisher Scientific stock in a transaction on Monday, February 5th. The shares were sold at an average price of $217.55, for a total transaction of $1,305,300.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Thermo Fisher Scientific Inc. (NYSE TMO) traded down $1.93 during trading hours on Wednesday, reaching $207.55. 1,653,024 shares of the company were exchanged, compared to its average volume of 1,683,668. Thermo Fisher Scientific Inc. has a 1 year low of $151.69 and a 1 year high of $226.44. The company has a current ratio of 1.35, a quick ratio of 0.92 and a debt-to-equity ratio of 0.74. The stock has a market cap of $82,790.00, a price-to-earnings ratio of 37.06, a price-to-earnings-growth ratio of 1.53 and a beta of 1.11.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Wednesday, January 31st. The medical research company reported $2.79 earnings per share for the quarter, beating analysts’ consensus estimates of $2.66 by $0.13. Thermo Fisher Scientific had a net margin of 10.64% and a return on equity of 16.01%. The firm had revenue of $6.05 billion for the quarter, compared to analyst estimates of $5.72 billion. During the same period last year, the firm posted $2.41 EPS. Thermo Fisher Scientific’s quarterly revenue was up 22.1% on a year-over-year basis. equities research analysts anticipate that Thermo Fisher Scientific Inc. will post 10.81 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Shareholders of record on Thursday, March 15th will be given a dividend of $0.17 per share. This is a positive change from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. This represents a $0.68 annualized dividend and a dividend yield of 0.33%. The ex-dividend date of this dividend is Wednesday, March 14th. Thermo Fisher Scientific’s payout ratio is presently 10.71%.

A number of brokerages have recently commented on TMO. Barclays lifted their target price on shares of Thermo Fisher Scientific from $225.00 to $245.00 and gave the company an “overweight” rating in a report on Thursday, February 1st. Leerink Swann reaffirmed an “outperform” rating and issued a $239.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a report on Thursday, February 1st. They noted that the move was a valuation call. ValuEngine raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Morgan Stanley lifted their price objective on shares of Thermo Fisher Scientific from $223.00 to $227.00 and gave the company an “overweight” rating in a research report on Thursday, February 1st. Finally, Bank of America lifted their price objective on shares of Thermo Fisher Scientific from $235.00 to $250.00 and gave the company a “buy” rating in a research report on Thursday, February 1st. Two research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $220.50.

Several hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. boosted its position in shares of Thermo Fisher Scientific by 2.4% during the 2nd quarter. Vanguard Group Inc. now owns 26,600,394 shares of the medical research company’s stock worth $4,640,970,000 after purchasing an additional 629,093 shares in the last quarter. BlackRock Inc. boosted its position in shares of Thermo Fisher Scientific by 1.6% during the 2nd quarter. BlackRock Inc. now owns 23,355,469 shares of the medical research company’s stock worth $4,074,828,000 after purchasing an additional 366,584 shares in the last quarter. Capital Research Global Investors boosted its position in shares of Thermo Fisher Scientific by 29.8% during the 2nd quarter. Capital Research Global Investors now owns 17,304,897 shares of the medical research company’s stock worth $3,019,185,000 after purchasing an additional 3,973,136 shares in the last quarter. Capital World Investors boosted its position in shares of Thermo Fisher Scientific by 6.1% during the 2nd quarter. Capital World Investors now owns 11,759,734 shares of the medical research company’s stock worth $2,051,721,000 after purchasing an additional 671,637 shares in the last quarter. Finally, Longview Partners Guernsey LTD boosted its position in shares of Thermo Fisher Scientific by 6.8% during the 4th quarter. Longview Partners Guernsey LTD now owns 4,876,890 shares of the medical research company’s stock worth $926,024,000 after purchasing an additional 311,977 shares in the last quarter. Institutional investors own 86.31% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Insider Selling: Thermo Fisher Scientific Inc. (TMO) Insider Sells 6,000 Shares of Stock” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another domain, it was copied illegally and republished in violation of United States and international copyright laws. The legal version of this story can be viewed at https://www.americanbankingnews.com/2018/02/07/insider-selling-thermo-fisher-scientific-inc-tmo-insider-sells-6000-shares-of-stock.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Insider Buying and Selling by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply